Cargando…
The Silence of PSMC6 Inhibits Cell Growth and Metastasis in Lung Adenocarcinoma
The proteasome has been validated as an anticancer drug target, while the role of a subunit of proteasome, PSMC6, in lung adenocarcinoma (LUAD) has not been fully unveiled. In this study, we observed that both the RNA and protein of PSMC6 were highly upregulated in LUAD compared with the adjacent no...
Autores principales: | Zhang, Jian-Yu, Shi, Ke-Zhi, Liao, Xiang-Yu, Li, Shi-Jun, Bao, Dan, Qian, Ying, Li, Dao-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235974/ https://www.ncbi.nlm.nih.gov/pubmed/34239933 http://dx.doi.org/10.1155/2021/9922185 |
Ejemplares similares
-
Silencing of PSMC2 inhibits development and metastasis of prostate cancer through regulating proliferation, apoptosis and migration
por: Chen, Qingke, et al.
Publicado: (2021) -
PSMC2/ITGA6 axis plays critical role in the development and progression of hepatocellular carcinoma
por: Duan, Xuhua, et al.
Publicado: (2021) -
circPSMC3: ceRNA and tumor suppressor
por: Lu, Chen, et al.
Publicado: (2019) -
PSMC1
variant causes a novel neurological syndrome
por: Aharoni, Sarit, et al.
Publicado: (2022) -
PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
por: Huang, Wei, et al.
Publicado: (2023)